2013

• Chen, R., Lambert, T. (2013), Managing cardiovascular risk factors in people with serious mental illness: the tragedy of neglect. Endocrinology Today. 2(1), 25-27.

2012

• Feiler, G., Chen, R., Pantelis, C., Lambert, T. (2012), Health behaviours of community-treated patients with psychosis. Australasian Psychiatry. 20(3), 208-213. [Abstract]
• O'Connor, N., Mulley, R., Grasso, B., Lambert, T., Snars, J., Jhita, P. (2012), An Acute Recovery Unit: the first 18 months. Australasian Psychiatry. 20(3), 214-219. [Abstract]
• Robillard, R., Rogers, N., Whitwell, B., Lambert, T. (2012), Are Cardiometabolic and Endocrine Abnormalities Linked to Sleep Difficulties in Schizophrenia? A Hypothesis Driven Review. Clinical Psychopharmacology and Neuroscience. 10(1), 1-12.
• Robillard, R., Lambert, T., Rogers, N. (2012), Measuring sleep¿wake patterns with physical activity and energy expenditure monitors. Biological Rhythm Research. 43(5), 555-562.
• Lambert, T., Emmerson, B., Hustig, H., Resseler, S., Jacobs, A., Butcher, B. (2012), Long acting risperidone in Australian patients with chronic schizophrenia: 24-month data from the e-STAR database. BMC Psychiatry. 12(1), 25. [Abstract]

2011

• Happell, B., Platania-Phung, C., Gray, R., Hardy, S., Lambert, T., McAllister, M., Davies, C. (2011), A role for mental health nursing in the physical health care of consumers with severe mental illness. Journal of Psychiatric and Mental Health Nursing. 18(8), 706-711. [Abstract]
• Lambert, T., Taylor, D. (2011), Pharmacology of antipsychotic long-acting injections. In: Antipsychotic Long-acting injections. (pp.23-46).United Kingdom: Oxford University Press.
• McGorry, P., Cocks, J., Power, P., Burnett, P., Harrigan, S., Lambert, T. (2011), Very Low-Dose Risperidone in First-Episode Psychosis: A Safe and Effective Way to Initiate Treatment. Schizophrenia Research and Treatment. 2011, 631690.
• Kelin, K., Lambert, T., Brnabic, A., Newton, R., Ye, W., Escamilla, R., Chen, K., Don, L., Montgomery, W., Karagianis, J., Ascher-Svanum, H. (2011), Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. Patient Preference and Adherence. 5, 213-222. [Abstract]
• Dalton, A., Lambert, T., Schrover, R., Hertel, J., Smith, D. (2011), The cost associated with administering risperidone long-acting injections in the Australian community. BMC Health Services Research. 11, 236. [Abstract]
• Lambert, T. (2011), Managing the metabolic adverse effects of antipsychotic drugs in patients with psychosis. Australian Prescriber. 34(4), 97-99.
• Lambert, T., Olivares, J., Peuskens, J., Desouza, C., Kozma, C., Otten, P., Crivera, C., Jacobs, A., Macfadden, W., Mao, L., Rodriguez, S., Dirani, R., Akhras, K. (2011), Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium. Annals of General Psychiatry. 10, 10. [Abstract]
• Lambert, T. (2011), Prescribing patterns and determinants of use of antipsychotic long-acting injections: an international perspective. In: Antipsychotic Long-acting Injections. (pp.209-230).United Kingdom: Oxford University Press.
• Patel, M., Matonhodze, J., Baig, M., Gilleen, J., Boydell, J., Holloway, F., Taylor, D., Szmukler, G., Lambert, T., David, A. (2011), Increased use of antipsychotic long-acting injections with community treatment orders. Therapeutic Advances in Psychopharmacology. 1(2), 37.
• Haddad, P., Lambert, T., Lauriello, J. (2011), The role of antipsycholtic long-acting injections in current practice. In: Antipsychotic Long-acting injections. (pp.241-260).United Kingdom: Oxford University Press.

2010

• Guastella, A., Einfeld, S., Gray, K., Rinehart, N., Tonge, B., Lambert, T., Hickie, I. (2010), Intranasal Oxytocin Improves Emotion Recognition for Youth with Autism Spectrum Disorders. Biological psychiatry. 67(7), 692-4. [Abstract]
• Lambert, T. (2010), Office for Psychiatric Evaluation and New Media (open). In: The Department of Psychiatry at the University of Melbourne 1964-2009: Personal Reminiscences. (pp.130-134).Australia: University of Melbourne.
• Lambert, T. (2010), Disease Management: Multidimensional Approaches to Incomplete Recovery in Psychosis. In: Advances in Biological Psychiatry: Therapy-Resistant Schizophrenia. (pp.87-113).Basel (Switzerland): S. Karger AG,.

2009

• Lambert, T., Singh, B., Patel, M. (2009), Community treatment orders and antipsychotic long-acting injections. British Journal of Psychiatry. 195(52), S57-S62. [Abstract]
• Lambert, T. (2009), Switching to aripiprazole from olanzapine leads to weight loss in overweight people with schizophrenia or schizoaffective disorder. Evidence - Based Mental Health. 12(2), 50. [Abstract]
• Lambert, T., Newcomer, J. (2009), Are the cardiometabolic complications of schizophrenia still neglected? Barriers to care. Medical Journal of Australia. 190(4 Suppl), S39-S42. [Abstract]
• Lambert, T. (2009), The medical care of people with psychosis. Medical Journal of Australia. 190, 171-172. [Abstract]
• Addington, J., Lambert, T., Burnett, P. (2009), Complete and incomplete recovery from first-episode psychosis. In: The Recognition and Management of Early Psychosis: A Preventive Approach. (pp.201-222).United Kingdom: Cambridge University Press.

2008

• Walter, G., Delaroche, A., Soh, N., Hunt, G., Cleary, M., Malhi, G., Lambert, T., Correll, C., Rey, J. (2008), Side effects of second-generation antipsychotics: the experiences, views and monitoring practices of Australian child psychiatrists. Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists. 16(4), 253-62. [Abstract]
• Sundram, S., Lambert, T., Piskulic, D. (2008), Acculturation is associated with the prevalence of tardive dyskinesia and akathisia in community-treated patients with schizophrenia. Acta psychiatrica Scandinavica. 117(6), 474-478. [Abstract]
• Lauriello, J., Lambert, T., Andersen, S., Lin, D., Taylor, C., McDonnell, D. (2008), An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia. The Journal of clinical psychiatry. 69(5), 790-9. [Abstract]
• Lambert, T., Norman, T. (2008), Ethnic differences in psychotropic drug response and pharmacokinetics. In: Ethno-psychopharmacology: Advances in Current Practice. (pp.38-61).United Kingdom: Cambridge University Press.

2007

• Iqbal, N., Lambert, T., Masand, P. (2007), Akathisia: problem of history or concern of today. CNS spectrums. 12(9 Suppl 1), 1-13. [Abstract]
• Elsom, S., Happell, B., Manias, E., Lambert, T. (2007), Expanded practice roles for community mental health nurses: a qualitative exploration of psychiatrists' views. Australasian Psychiatry. 15(4), 324-328. [Abstract]
• Subramaniam, M., Ng, C., Chong, S., Mahendran, R., Lambert, T., Pek, E., Huak, C. (2007), Metabolic differences between Asian and Caucasian patients on clozapine treatment. Human psychopharmacology. 22(4), 217-222. [Abstract]
• Weiden, P., Miller, A., Lambert, T., Buckley, P. (2007), The art and science of switching antipsychotic medications, part 2. The Journal of clinical psychiatry. 68(1), e02. [Abstract]
• Lambert, T. (2007), Switching antipsychotic therapy: what to expect and clinical strategies for improving therapeutic outcomes. The Journal of clinical psychiatry. 68(Suppl 6), 10-13. [Abstract]
• Berk, M., Fitzsimons, J., Lambert, T., Pantelis, C., Kulkarni, J., Castle, D., Ryan, E., Jespersen, S., McGorry, P., Berger, G., Kuluris, B., Callaly, T., Dodd, S. (2007), Monitoring the safe use of clozapine: a consensus view from Victoria, Australia. CNS drugs. 21(2), 117-127. [Abstract]